Editor`s Picks

The final estimate for Q4 GDP growth in the U.S. is revised up to 3.4%, fueled by robust consumer spending and nonresidential fixed investment. A slight decrease in jobless claims to 210,000 further...

The S&P 500 closed out a blowout month and quarter at a new record high to notch its best start to a year since 2019. Identifying promising opportunities becomes paramount amid the current...

After a sluggish 2023, 2024 looks brighter for healthcare stocks. Numerous demographic and social factors also argue in favor of a long-term rise. What are the best healthcare stocks to buy...

Despite a challenging year with a stock price drop of over 41%, ACADIA Pharmaceuticals is seen by InvestingPro and Wall Street analysts as undervalued, with expectations of significant upside...

Today, we'll explore stocks offering promising dividends alongside potential growth opportunities and market favor. These stocks embody a coveted blend of strong dividends, promising earnings,...

As US index futures hint at a subdued start today amid lingering concerns about stretched valuations, especially on the S&P 500. Awaiting key data releases, investors remain watchful for any...

Humana's stock has seen a 24% drop YTD due to slashed profit forecasts. Wall Street responded with analyst downgrades and lowered EPS expectations ahead of the Q1 report. Despite challenges,...

The S&P 500 is off to a strong start to the year, topping the 5,200-level for the first time ever. The benchmark index is set to extend its record rally amid favorable market conditions. As such,...